You want to quash 'Low-T' overprescription, FDA? Quash DTC ads, experts urge

After warning that casual use of testosterone meds can cause heart attack and stroke, the FDA has finally put its foot down to curb overprescribing of the drugs. But some say the agency needs to go further--and that means putting the kibosh on the marketing campaigns that have helped swell their market past $2 billion. More from FiercePharmaMarketing